The cognitive problems in early-to-moderate AD are treated with Acetylcholinesterase inhibitors (Donepezil, Rivastigmine, and Galantamine) which block the degradation of acetylcholine and enhance cholinergic neurotransmission, deficient in AD. The gene discussed is ACHE; the disease is Alzheimer disease.